Evidence map›Paper›PMID 28127211›Full record

ArticleWorld journal of gastroenterology2017

Posterior reversible encephalopathy syndrome in alcoholic hepatitis: Hepatic encephalopathy a common theme.

Elizabeth S John, Ramy Sedhom, Ishita Dalal, Ranita Sharma

Open access · hybridAbstract readCase Reports
In one paragraph

Article in World journal of gastroenterology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Elizabeth S JohnElizabeth S John, Ramy Sedhom, Ishita Dalal, Ranita Sharma, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, United States.
Ramy SedhomElizabeth S John, Ramy Sedhom, Ishita Dalal, Ranita Sharma, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, United States.
Ishita DalalElizabeth S John, Ramy Sedhom, Ishita Dalal, Ranita Sharma, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, United States.
Ranita SharmaElizabeth S John, Ramy Sedhom, Ishita Dalal, Ranita Sharma, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, United States.
Johnson University · USRutgers, The State University of New Jersey · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a neuro-radiologic diagnosis that has become more widely recognized and reported over the past few decades. As such, there are a number of known risk factors that contribute to the development of this syndrome, including volatile blood pressures, renal failure, cytotoxic drugs, autoimmune disorders, pre-eclampsia, and eclampsia. This report documents the first reported case of PRES in a patient with severe alcoholic hepatitis with hepatic encephalopathy and delves into a molecular pathophysiology of the syndrome.

Indexed as

AcetamidesAdultAnticonvulsantsAscitesBrainElectroencephalographyFemaleGastrointestinal AgentsHepatic EncephalopathyHepatitis, AlcoholicHumansLacosamideLactuloseLiver Function TestsMagnetic Resonance ImagingPatient ComplianceAcetamidesAnticonvulsantsGastrointestinal AgentsLacosamideLactuloseRifamycinsRifaximinSerum AlbuminAlcoholic hepatitisHeadachesHepatic encephalopathyPosterior reversible encephalopathy syndromeSeizure

Identifiers

PMID28127211
PMCPMC5236517
OpenAlexW2572582274

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.